Two-stage tumor promotion in mouse skin: an alternative interpretation.
D015127:9,10-Dimethyl-1,2-benzanthracene / Q000633:toxicity; D000818:Animals; D002273:Carcinogens / Q000037:antagonists & inhibitors / Q000633:toxicity*; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced / Q000517:prevention & control; D002471:Cell Transformation, Neoplastic / Q000139:chemically induced* / Q000517:prevention & control; D003043:Cocarcinogenesis; D003436:Croton Oil / Q000633:toxicity; D005446:Fluocinolone Acetonide / Q000494:pharmacology; D051379:Mice; D008815:Mice, Inbred Strains; D010212:Papilloma / Q000139:chemically induced / Q000517:prevention & control; D012867:Skin / Q000187:drug effects; D012878:Skin Neoplasms / Q000139:chemically induced* / Q000517:prevention & control; D013755:Tetradecanoylphorbol Acetate / Q000037:antagonists & inhibitors / Q000633:toxicity; D014108:Tosylphenylalanyl Chloromethyl Ketone / Q000494:pharmacology; D014212:Tretinoin / Q000494:pharmacology
D002273:Carcinogens; D005446:Fluocinolone Acetonide; D014108:Tosylphenylalanyl Chloromethyl Ketone; D014212:Tretinoin; D015127:9,10-Dimethyl-1,2-benzanthracene; D003436:Croton Oil; D013755:Tetradecanoylphorbol Acetate